The World Eye and Vision Congress which brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostic companies, leading universities and clinical research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. Ophthalmology Congress maximizes the opportunity to interact with and learn from your peers from across the country and across the globe it held with the discussions on Cornea and External Eye Disease, Retina and Retinal Disorders, Neuro-Ophthalmology, Glaucoma: Visual Field Loss, Ocular Microbiology and Immunology, Novel Approaches to Ophthalmology Therapeutics and many more.

Refractive Surgery Ocular Surface Disease

The refractive surgery team uses precision laser eye surgery techniques and specialised lens implants to correct focusing problems such as short sight (myopia), long sight (hypermetropia), irregular focus (astigmatism) and loss of reading vision (presbyopia). A refractive error, for example, partial blindness (near sightedness), farsightedness (hyperopia), astigmatism or presbyopia, refractive surgery is a strategy for revising or enhancing vision. There are different surgical methods for modifying eye's centering capacity by reshaping the cornea, or clear, round vault at the front of your eye. Different techniques include embedding a focal point inside the eye. The most generally performed kind of refractive surgery is LASIK (laser-aided situ keratomileusis), where a laser is utilized to reshape the cornea. For individuals who are myopic, certain refractive surgery systems will diminish the bend of a cornea that is excessively steep so that the eye's centering power is reduced. Pictures that are engaged before the retina, because of a more drawn out eye or soak corneal bend, are driven nearer to or specifically onto the retina following surgery. Pictures that are locked in past the retina, due to a short eye or level cornea, will be pulled closer to or particularly onto the retina after surgery.

Glaucoma

Glaucoma is a multifactorial optic neuropathy that influences more than 50 million populations and is the second driving reason for visual deficiency around the world. Glaucoma is brought on because of the harm of the optic nerve , which prompts to high intraocular weight and on the off chance that it is untreated then it will increments to vision misfortune with the start of imperceptibly blind sides at the edges of visual field took after by visual deficiency. Optic nerve harm is the primary driver for glaucoma alongside the few fundamental causes which are obscure. As indicated by world wellbeing association (WHO) glaucoma is the second real reason for visual deficiency over the globe. The clutters can be generally partitioned into two principle classifications, open-point glaucoma and shut edge glaucoma.

Retina: Innovations, Research, New tech

Any eye issue identification is mostly finished with the assistance of innovation. The eye is an extremely delicate organ, and the internal conclusions of the eye are impossible with the assistance of innovation. Hence, the advancement in the eye is vital for discovery and treatment of eye abandons. In this quickly developing innovation world, there are a huge number of advancements and thoughts. Advancement in eye causes the visually impaired individuals to see the world as per their craving. Eye mind encourages us to know the vision needs. It shows thorough eye mind goes past a medicine for glasses or contact focal points.

The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded directly through mail id: ophthalmologist@eclinicalsci.com or forwarded to the Editorial Office at  https://www.pulsus.com/ophthalmologist-clinical-therapeutic-journal.html

Media Contact:
Sarah Rose
Journal Manager
The Ophthalmologist: Clinical and Therapeutic Journal 
Email: ophthalmologist@eclinicalsci.com
Watsapp:+1-947-333-4405